NA
DXCM icon

NewEdge Advisors’s DexCom DXCM Stock Holding History

NewEdge Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
26,895
-3,302
-11% -$230K 0.01% 1194
2025
Q4 		$2M Buy
30,197
+17,694
+142% +$1.14M 0.01% 1075
2025
Q3 		$841K Sell
12,503
-6,750
-35% -$534K ﹤0.01% 1497
2025
Q2 		$1.68M Buy
19,253
+258
+1% +$20.2K 0.01% 1021
2025
Q1 		$1.3M Sell
18,995
-4,910
-21% -$401K 0.01% 1047
2024
Q4 		$1.86M Buy
23,905
+13,159
+122% +$974K 0.01% 858
2024
Q3 		$720K Buy
10,746
+1,726
+19% +$142K ﹤0.01% 1263
2024
Q2 		$1.02M Buy
9,020
+1,393
+18% +$176K 0.01% 1052
2024
Q1 		$1.06M Buy
7,627
+522
+7% +$65.6K 0.01% 975
2023
Q4 		$896K Sell
7,105
-52
-0.7% -$5.31K 0.01% 987
2023
Q3 		$668K Buy
7,157
+2,927
+69% +$330K 0.01% 1048
2023
Q2 		$544K Buy
4,230
+393
+10% +$47.5K 0.01% 1145
2023
Q1 		$446K Sell
3,837
-2,388
-38% -$267K 0.01% 1155
2022
Q4 		$696K Buy
+6,225
New +$683K 0.02% 646
2022
Q1 		– Sell
-6,748
Closed -$906K – 1283
2021
Q4 		$906K Buy
+6,748
New +$970K 0.01% 780
2020
Q4 		– Sell
-5,864
Closed -$604K – 1011
2020
Q3 		$604K Sell
5,864
-6,612
-53% -$691K 0.02% 514
2020
Q2 		$1.26M Buy
12,476
+6,412
+106% +$574K 0.05% 306
2020
Q1 		$408K Sell
6,064
-244
-4% -$15.2K 0.02% 511
2019
Q4 		$344K Sell
6,308
-908
-13% -$43.1K 0.01% 625
2019
Q3 		$283K Buy
+7,216
New +$280K 0.01% 651

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NewEdge Advisors's DXCM Position: Q1 2026 in Review

NewEdge Advisors reduced its DexCom (DXCM) stake by 11% in Q1 2026, selling an estimated $230K and leaving 26,895 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #1194.

NewEdge Advisors first reported a position in DXCM in Q3 2019 and has held it in 20 quarters since. The position peaked at $2M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • NewEdge Advisors held 26,895 shares of DexCom worth $1.69M as of Q1 2026.
  • NewEdge Advisors sold 3,302 DexCom shares in Q1 2026, an estimated $230K.
  • DexCom made up 0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1194 holding.
  • NewEdge Advisors first reported a position in DexCom in Q3 2019 and has held it in 20 quarters since.
  • NewEdge Advisors's DexCom position peaked at $2M in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.